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InternalizationOxidative stress is a feature of cholestatic syndrome and induces multidrug resistance-associated protein 2
(Mrp2) internalization from the canalicular membrane surface. We have previously shown that the activation
of a novel protein kinase C (nPKC) by oxidative stress regulates Mrp2 internalization. The internalized Mrp2
was recycled to the canalicular surface in a protein kinase A (PKA)-dependent manner after intracellular
glutathione (GSH) levels were replenished. However, the putative phosphorylation targets of these protein
kinases involved in reversible Mrp2 trafﬁcking remain unclear. In this study, we investigated the effect of
changing the intrahepatic redox status on the C-terminal phosphorylation status of radixin (p-radixin), which
links Mrp2 to F-actin, and the interaction of p-radixin with Mrp2 in rat hepatocytes. We detected a signiﬁcant
decrease in the amount of p-radixin that co-immunoprecipitatedwithMrp2 after tertiary-butylhydroperoxide
(t-BHP) treatment. After treatment with GSH-ethylester (GSH-EE), the phosphorylation level became the
same as that of the control. A PKC and protein phosphatase (PP)-1/2A inhibitor, but not a PP-2A selective
inhibitor, prevented the t-BHP-induced decrease of p-radixin and subsequent canalicular Mrp2 localization. In
contrast, a PKA inhibitor affected the recovery process facilitated by GSH-EE treatment. In conclusion, the
interaction of p-radixin with Mrp2 was decreased by the activation of PKC and PP-1 under oxidative stress
conditionswhich subsequently led toMrp2 internalization, whereas the interaction of p-radixin andMrp2was
increased by the activation of PKA during recovery from oxidative stress.protein 2; BSEP, bile-salt export
-BHP, tert-butylhydroperoxide;
, ezrin/radixin/moesin; cPKC,
ts; SDR, Sprague–Dawley rats;
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Multidrug resistance-associated protein 2 (MRP2/ABCC2) and
bile-salt export pump (BSEP/ABCB11) are involved in the formation
of bile-salt-independent and -dependent bile ﬂow, respectively. MRP2
is expressed statically on the canalicular surface, but MRP2 dynamic
insertion and internalization processes are also of great importance
because the steady-state expression level of MRP2 is directly
dependent on its turnover rate. It is suggested that the disruption of
these turnover rates leads to cholestatic jaundice. Disrupted canalic-
ular localization of MRP2 has been observed in patients with chronic
cholestatic disorder and hepatic failure, i.e., primary biliary cirrhosis
(PBC) and hepatitis C virus infection) [1]. Oxidative stress markerswere also closely correlated in these chronic liver failure patients [2].
These observations strongly suggest that both the mRNA expression
of canalicular transporters, and their localization are of equal
importance in human liver failure.We have previously demonstrated
that Mrp2 internalization is observed when acute oxidative stress is
induced in rat livers using ethacrynic acid-, tert-butylhydroperoxide
(t-BHP) and lipopolysaccharide (LPS) [3–6].We have also shown that
Mrp2 localization returns to the canalicular membrane after the
replenishment of intracellular GSH [5]. Microtubule polymerization
and protein kinase A (PKA) are essential factors in the Mrp2 sorting
process, which suggests that the balance between PKC activation and
PKA activation is a key regulator of reversible Mrp2 trafﬁcking. The
molecular phosphorylation targets of protein kinases that reversibly
regulate canalicular Mrp2 localization remain unclear.
The ezrin/radixin/moesin (ERM) protein family link cytoskeletal
actinﬁlaments (F-actin) and integralmembraneproteins. The anchoring
function of ERMproteins is regulated by the C-terminal phosphorylation
status of these proteins, via the transition between active (C-terminal
phosphorylated) and inactive (C-terminal dephosphorylated) forms
[7]. Radixin is the dominant ERM protein in the canalicular membrane
of the liver. Mice lacking radixin develop conjugated hyperbilirubinemia
because of their impaired ability to localize Mrp2 to the canalicular
membrane surface, which suggests that radixin is required for
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Mrp2/MRP2 and radixin, as well as endocytic retrieval of MRP2, was
observed in the liver of PBC patients and in several experimental
cholestaticmodels,which suggests that theremaybe an associationwith
a failure in the anchoring of Mrp2/MRP2 to the canalicular membrane
[1,9].We showed that conventional PKC (cPKC) activation decreases the
amount of the active form (C-terminal phosphorylated form) of ezrin
which reduces the protein–protein interaction between ezrin andMrp2
in the rat small intestine [10]. LPS induced a change in the C-terminal
phosphorylation status of radixin, which led to its dissociation from
Mrp2 and subsequent internalization in rat liver [11]. Although it has
been reported that the C-terminal phosphorylation status of radixin
regulates the canalicular Mrp2 localization [12], the redox sensitive
activationof protein kinasesorphosphatases that aredirectly involved in
the dephosphorylation of the C-terminus threonine (Thr564) of radixin
have not been elucidated. In this study, we tested the hypothesis that
radixin is the phosphorylation target of redox-sensitive protein kinases
that regulate reversible Mrp2 localization. We tested this hypothesis
using an in situ rat liver perfusion study and isolated rat hepatocyte
couplets (IRHCs). Our results indicate that the interactionof C-terminally
(Thr564) phosphorylated radixin (p-radixin) with Mrp2 was decreased
by the activation of protein phosphatase 1 triggered by the PKC
activation under oxidative stress conditions. This subsequently led to
Mrp2 internalization, whereas the interaction between p-radixin and
Mrp2was increased by the activation of PKAduring the recoveryprocess
from oxidative stress. The balance of the activation between PKA and
PKC was accompanied by the variations in intercellular GSH content,
which were determined by the phosphorylation status of radixin. A
change in the phosphorylation status of radixin reversibly regulates the
protein interaction between the p-radixin and Mrp2, and the redox-
sensitive canalicular localization of Mrp2.
2. Materials and methods
2.1. Chemicals and antibodies
t-BHP and glutathione-reduced ethyl ester (GSH-EE) were obtained
from Sigma-Aldrich Chemicals (St. Louis, MO). Gö6850 and protein
kinase A inhibitor 14–22 amide, cell-permeable myristoylated, were
from Calbiochem (Darmstadt, Germany). Rabbit anti-Mrp2 polyclonal
antibody (EAG15)was raised against the 12-amino acid sequence at the
carboxyl terminus of rat Mrp2, as previously described by Keppler [13].
Rabbit anti-phosphorylated ezrin (Thr567)/radixin (Thr564)/moesin
(Thr558) (p-ERM) antibody was purchased from Millipore (Temecula,
CA). Rat anti-radixin (R21) was kindly provided by Dr. Sachiko Tsukita
(OsakaUniversity, Japan). Thehorseradishperoxidase-linked secondary
antibodies used in the immunoblot analysis were obtained from Santa
Cruz Biotechnology Inc. (Santa Cruz, CA). All chemicals and solvents
were of analytical grade.
2.2. Animals
Male Sprague–Dawley rats (SDR) weighing 170–220 g (six to
sevenweeks old) obtained from Japan SLC Inc. (Shizuoka, Japan) were
used in the study. The animals were treated humanely in accordance
with the guidelines issued by the National Institutes of Health and all
protocols were approved by the animal care and use committee of
Chiba University.
2.3. Rat liver perfusion
Rat livers were perfused in situ in a non-recirculating system with
Krebs–Henseleit bicarbonate buffer (120 mM NaCl, 4.7 mM KCl,
2.5 mM CaCl2, 5 mM glucose, pH 7.4, at 37 °C), as previously described
[3]. Rat livers were perfused with or without 500 μM t-BHP for 30 min
and subsequently perfused for 1 h with 3 mMGSH-EE (cell permeableform of GSH). Liver samples weighing 2 g were snap-frozen in liquid
nitrogen.
2.4. IRHC preparation
Hepatocytes were isolated from SDR liver using limited collage-
nase digestion, as previously described [14]. After isolation, rat
hepatocytes were maintained (5×105 cells/mL) prior to seeding at
4 °C in Williams' medium E supplemented with 10% fetal bovine
serum, penicillin (100,000 units/mL) and streptomycin (100 μg/mL).
Cell viability was assessed by trypan blue exclusion and remained
greater than 92%.
2.5. Cell processing
Cell processingwas performed as previously described, but with the
followingmodiﬁcations [3,4,15]. Hepatocyteswereplated at a density of
2.5×106 cells per 60 mmculture plate andmaintained at 37 °C for 3 h in
a CO2 incubator. Cells were added to 100 μM t-BHP and incubated for
10 min. Themediumwas subsequently replacedwith 3 mMGSH-EE for
30 min. In inhibition experiments, cells were pretreated with inhibitors
for 30 min prior to exposure to t-BHP. After the treatments, cells were
scraped into ice-cold buffer A (20 mM Tris, 250 mM sucrose, 5 mM
EGTA, 1 mM MgCl2) supplemented with 1 mM phenylmethylsulfonyl
ﬂuoride, and a 0.1% protease inhibitor cocktail, before immediate
sonication using a Taitec VP-5S (Saitama, Japan).
2.6. Measurement of intracellular GSH content
Samples were mixed with 3-ﬂuorotyrosine as an internal standard,
followed by ﬁltration through a 0.45-μm Millex-LH syringe ﬁlter from
Millipore (Bedford, MA). HPLC was performed as described previously
[16]. Chromatographic separation was achieved using an Inertsil ODS
column (4.6 mm internal diameter×250 mm; GL Sciences Ltd., Tokyo,
Japan) with 0.1% triﬂuoroacetic acid:methanol (20:1) as the mobile
phase at a ﬂow rate of 1.0 mL/min. Eluate from the column was mixed
with a solution containing 18.6 mM o-phthalaldehyde and 17.1 mM 2-
mercaptoethanol in 100 mM carbonate buffer (pH 10.5), delivered at a
rate of 0.2 mL/min. The mixture was then passed through a stainless
steel coil at 70 °C to facilitate derivatization. A ﬂuorescence detector at
an excitation wavelength of 355 nm and an emission wavelength of
425 nmwas used. The reduced GSH concentration was calculated with
reference to the height of the standard reduced GSH sample.
2.7. Western blot analysis
The homogenate (20 μg protein for radixin and 45 μg protein for p-
radixin) prepared from treated rat hepatocytes was separated using 8.5%
polyacrylamide slab gel containing 0.1% SDS before electrophoretic
transfer to an Immobilon-P transfer membrane ﬁlter (Millipore Corpo-
ration, Billerica, MA). Themembranewas blocked overnight at 4 °C using
TTBS (Tris-buffered saline with 0.05% Tween 20) containing 3% bovine
serum albumin (BSA), before being probed at room temperature for 1 h
with primary antibodies diluted with TTBS containing 0.1% BSA. The
membrane was incubated for 1 h at room temperature with secondary
antibodies conjugated with horseradish peroxidase and diluted with
TTBS containing 0.1% BSA. Themembranewas visualizedwith ChemiDoc
(Bio-Rad Laboratories Inc., CA.) using an enhanced chemiluminescence
system (GE Healthcare, Little Chalfont, UK).
2.8. Immunoﬂuorescence analysis
Small frozen blocks of liver were embedded in Tissue-Tek O.C.T.
compound (Sakura Finetechnical Co. Ltd., Tokyo, Japan) and cut into
5-μm thick sections at −25 °C, before acetone ﬁxation at room
temperature for 10 min. Sections were hydrated on slides for 15 min
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certain experiments, isolated hepatocytes were plated on glass cover
slips at a density of 2.0×105 cells/mL/12-wells and incubated in a CO2
incubator for 3 h to form IRHCs. These were then further incubated for
10 min with or without 100 μM t-BHP. In other experiments, cells were
pretreated with inhibitors for 30 min, prior to exposure to t-BHP. IRHCs
were ﬁxed with 4% formaldehyde/PBS for 15 min and permeabilized in
0.1% TritonX-100/PBS for 10 min.Afterﬁxation, the rat liver sectionsand
IRHCs were probed with anti-Mrp2 antiserum (1:50) and antibodies to
the active form of radixin (p-ERM) (1:25) for 1 h. Samples were washed
with PBS and incubated for 1 h with FITC and/or Alexa 546-conjugated
secondary antibodies (1:250). Antibodieswere diluted in PBS containing
1% bovine serum albumin. IRHC samples were treated with 0.2 mg/mL
RNase A in PBS for 20 min at room temperature, prior to mounting on a
Vectashield (Vector Laboratories, Burlingame, CA.) containing propi-
dium iodide to reduce background ﬂuorescence. Cells and liver sections
were blind analyzed using a Carl Zeiss LSM510 confocal laser scanning
microscope (Jena, Germany). We randomly chose ten ﬁelds per cover
slip and counted the nuclei (30 to 50 nuclei per ﬁeld) and Mrp2. The
ratios Mrp2-positive pseudocanaliculi per cell nucleus was calculated to
deﬁne the Mrp2-index and processed for statistical analysis.Control
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(B) μ2.9. Immunoprecipitation analysis
Treated IRHCs were lysed for 1 h at 4 °C with lysis buffer (25 μl/mg
protein) containing 25 mM Tris/HCl, pH 7.5, 5 mM EDTA, 250 mM
NaCl, 1% (v/v) Triton X-100, 60 mM n-octyl-β-D-glucopyranosid,
50 mM NaF, 1 mM Na3VO4, and protease inhibitor (1 mM PMSF,
5 μg/mL leupeptin, and 1 μg/mL pepstatin A). The tissue homogenate
was centrifuged at 20,630 g for 10 min. The supernatant was collected
as tissue lysate and rotated overnight at 4 °C with protein G and anti-
Mrp2 antibody. The beads were centrifuged at 9170 g for 1 min and
washed three timeswith awash buffer containing 25 mMTris/HCl, pH
7.5, 5 mM EDTA, 150 mM NaCl, 1% (v/v) Triton X-100, 50 mM NaF,
and 1 mM Na3VO4. Finally an elution buffer containing 10 mM
Tris/HCl, pH 6.5, 3% (w/v) SDS, 10% (v/v) glycerol, 5% (v/v) β-
mercaptoethanol, 8 M urea, and 0.001% bromophenol blue was added,
before heating at 95 °C for 5 min. The suspensionwas centrifuged, and
the supernatant was analyzed by SDS-polyacrylamide gel electropho-
resis, followed by immunoblot analysis.2.10. Statistical analysis
Data were calculated as mean±S.D. We analyzed data statistically
using Bonferroni correction.We considered differences inmeans to be
signiﬁcant at the pb0.05 level.Table 1
Mrp2 localization is reversibly regulated by the intracellular redox status in IRHCs.
IRHCs were treated with/without 100 μM t-BHP for 10 min, and then treated
with/without 3 mM GSH-EE for 30 min. Both the intracellular GSH content and
Mrp2-index decreased to approximately half that of the control treatment after
exposure to 100 μM t-BHP but recovered to match the control value after treatment
with 3 mM GSH-EE for 30 min. Results are shown as mean±S.D. of four cell
preparations.
GSH content (nmol/106 cells) Mrp2-index (%)
Control 27.3±2.5 11.8±1.3
t-BHP (100 μM) 12.5±3.6⁎⁎⁎ 5.9±2.0⁎⁎
GSH-EE (3 mM) 30.3±4.2### 12.6±1.0###
t-BHP/GSH-EE 32.6±5.5### 10.1±1.5##
⁎⁎⁎ pb0.005, signiﬁcantly different from control.
⁎⁎ pb0.01, signiﬁcantly different from control.
### pb0.005, signiﬁcantly different from t-BHP 100 μM.
## pb0.01, signiﬁcantly different from t-BHP 100 μM.3. Results
3.1. Mrp2 localization was reversibly regulated by the intracellular redox
status in IRHCs
t-BHP is known to be highly extracted by the liver in a single
perfusion [17] and catalyzed by glutathione peroxidase [18], while GSH-
EE is known as a cell-permeable form of GSH that undergoes hydrolysis
by intracellular esterases, thereby increasing the intracellular GSH level
rapidly. The IRHC is an established experimental system that maintains
apical–basal polarity and endogenous liver-speciﬁc protein expressionGSH-EE 3 mM
Green: Mrp2 
Red: p-radixin
Fig. 1. Effect of GSH-EE perfusion on the decreased GSH content (A) and canalicular
Mrp2/p-radixin localization (B) in perfused rat livers. Rat liver perfusions were ended
at the indicated time point and sampled before the preparation of frozen sections.
Measurement of intrahepatic GSH content and immunoﬂuorescence analysis (confocal
laser-scanning microscopy) of the perfused rat liver were performed. Frozen sections
(6 μm in thickness) of acetone-ﬁxed tissue were stained with anti-Mrp2 (green) and p-
ERM (red) antibodies and examined using a confocal laser-scanning microscope. The
decreased GSH content and the disruptedMrp2 and p-radixin localization in canalicular
domain induced by 500 μM t-BHP for 30 min were restored to the canalicular domain
by the subsequent perfusion with 3 mM GSH-EE for 60 min. *pb0.05, **pb0.01,
signiﬁcantly different from control. ##pb0.01, signiﬁcantly different from t-BHP
500 μM. Scale bar, 50 μm.
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Fig. 2. Effect of protein kinase inhibitors on changes in radixin expression (B), p-radixin expression (C) andMrp2-index in IRHCs, which were induced by t-BHP and/or GSH-EE. IRHCs
were pretreated with/without protein kinase inhibitors for 30 min, and the cells were subsequently treated with t-BHP and GSH-EE. Total radixin expression (B), active form of
radixin (p-radixin; C) and Mrp2-index were analyzed following the treatments. Both decreased p-radixin expression and Mrp2-index induced by the t-BHP exposure were
suppressed by the pretreatment with Gö6850 (PKC inhibitor). In contrast, the recovery of p-radixin expression and Mrp2-index induced by the GSH-EE was suppressed by the
pretreatment with a PKA inhibitor. Results are shown as the mean±S.D. for four independent IRHCs isolations. *pb0.05, **pb0.01, signiﬁcantly different from control. #pb0.01,
signiﬁcantly different from t-BHP 100 μM.
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canalicular space between adjacent hepatocytes couplets but was
reorganized after isolation for approximately 3 h. We calculated the
ratio of Mrp2-positive pseudocanaliculi per cell nucleus to deﬁne the
Mrp2-index, as previously described [4]. We conﬁrmed the relationship
between intracellular GSH level and the Mrp2-index in IRHCs, as
reported in the in situ liver perfusion study (Table 1; [5]). The
intracellular GSH decreased to about half of the control after exposure
to 100 μM t-BHP for 10 min. Intracellular GSH was completely restored
by subsequent treatment with 3 mM GSH-EE for 30 min (Table 1).
Likewise, the Mrp2-index was decreased and restored by t-BHP and
subsequent GSH-EE treatment, respectively (Table 1).
3.2. Effect of t-BHP and GSH-EE perfusion on the intracellular GSH
content and canalicular Mrp2 and p-radixin localization in perfused rat
livers
As previously reported, 500 μM t-BHP perfusion led to a decrease
of the hepatic reduced form of GSH by more than half of controlwithin 30 min after perfusion [19]. In addition, hepatic GSH content
remained low after subsequent KHB buffer perfusion for 60 min. On
the other hand, subsequent 3 mM GSH-EE perfusion for 60 min
replenished the hepatic GSH content almost completely (91.1±4.6%
of control) (Fig. 1A). Previous studies reported that 3 h treatment
with LPS led to changes in the localization of Mrp2 and radixin
from the canalicular membrane [11]. We then investigated whether
the modiﬁed canalicular localization of p-radixin induced by t-BHP
and GSH-EE was accompanied by changes in the intracellular
GSH concentration. Immunoﬂuorescence analysis showed the co-
localization of Mrp2 and p-radixin in rat liver controls. Mrp2 and
radixin staining was reduced in liver perfused with t-BHP (500 μM
for 30 min), and co-localization was partially disrupted (Fig. 1B). In
contrast, Mrp2 and p-radixin co-localization in the canalicular
surface was restored by GSH-EE (3 mM) perfusion for 30 min,
which induced the replenishment of intracellular GSH (Fig. 1B). Our
data suggest that radixin phosphorylation status might regulate
reversible Mrp2 localization, which is accompanied by a change in
the intracellular redox status.
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Fig. 3. Effects of protein kinase inhibitors on changes in the Mrp2-p-radixin interaction in IRHCs, which were induced by t-BHP and/or GSH-EE. IRHCs were pretreated with/without
protein kinase inhibitors for 30 min, and cells were subsequently treated with t-BHP and/or GSH-EE. The interaction of Mrp2 with p-radixin was analyzed after treatments. The
decreased interaction between Mrp2 and p-radixin, which was induced by t-BHP treatment, was suppressed by pretreatment with Gö6850 (PKC inhibitor). In contrast, the recovery
of the interaction induced by GSH-EE was suppressed by pretreatment with a PKA inhibitor. Results are shown as the mean±S.D. for four independent IRHC isolations. **pb0.01,
signiﬁcantly different from control. ###pb0.005, signiﬁcantly different from t-BHP 100 μM.
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phosphorylation status of radixin and Mrp2 localization in IRHCs
induced by t-BHP and/or GSH-EE
We previously reported that the dephosphorylation of C-terminal
phosphorylated radixin occurs without a change in the total radixin
expression (both activated and inactivated forms) after a 3 h
treatment with LPS [11]. Previous reports also indicated that
conventional PKC (cPKC) activation decreases the amount of the
active form (C-terminally phosphorylated) of ezrin, which diminishes
the protein–protein interaction between ezrin and Mrp2 in the rat
small intestine [10]. We investigated the effect of GSH-EE and protein
kinase inhibitors on the dephosphorylation of C-terminally phos-
phorylated radixin in acute oxidative stress conditions induced by t-
BHP. Total radixin expression in the t-BHP-treated homogenate
(phosphorylated and dephosphorylated forms) was comparable to
that observed with other treatments (106.6±7.8%; Fig. 2B). In
addition, the p-radixin content of the t-BHP-treated homogenate
was signiﬁcantly reduced compared to the control (75.3±8.8%).
Subsequent GSH-EE treatment restored the t-BHP-induced decrease
of p-radixin to control levels (103.3±12.3%; Fig. 2C). Pretreatment
with Gö6850 (PKC inhibitor) suppressed the t-BHP-induced decrease
of p-radixin to control levels (121.1±11.5%; Fig. 2C). In contrast, the
recovery of p-radixin after GSH replenishment was signiﬁcantly
inhibited in the presence of a PKA inhibitor (43.9±9.0%), thereby
affecting the decrease of p-radixin expression induced by t-BHP
exposure (42.1±9.7%; Fig. 2C). We conﬁrmed that the PKC inhibitor
prevented the t-BHP induced decrease of Mrp2-index, but it did not
affect its recovery process by GSH-EE treatment. However, the, PKA
inhibitor did not affect the t-BHP induced decrease of Mrp2-index,
but affected its recovery by GSH-EE treatment (Fig. 2D). Our data
suggest that C-terminally phosphorylated radixin is converted to its
dephosphorylated form by t-BHP treatment. The dephosphorylated
form of radixin was restored when the intracellular GSH content wasreplenished. Phosphorylation status is strictly regulated by the
activation of PKC (dephosphorylation of p-radixin) and PKA
(phosphorylation of radixin).
3.4. Effect of protein kinase inhibitors on changes in Mrp2-p-radixin
interaction in IRHCs induced by t-BHP and/or GSH-EE
We investigated the molecular interaction of Mrp2 with p-radixin
using immunoprecipitation analysis to obtain insight into themolecular
mechanism involved in reversible Mrp2 localization, which is accom-
panied by changes in the intracellular redox status. P-radixin was
readily co-immunoprecipitated with Mrp2 in the control cell lysate, as
describedpreviously [8]. The interaction betweenMrp2 and radixinwas
not detected when pre-immune rabbit IgG was used in the immuno-
precipitation experiment (data not shown). The amount of Mrp2
immunoprecipitated with anti-Mrp2 antibody was unchanged in all
treatments, whereas the amount of p-radixin in the immunoprecipitate
was decreasedby t-BHP treatment (31.4±10.5%; Fig. 3). In contrast, the
t-BHP-induced decrease in theMrp2-p-radixin interactionwas restored
by replenishment of intrahepatic GSH content. Pretreatment with
Gö6850 suppressed the t-BHP-induced decrease in the Mrp2-p-radixin
interaction down to control levels (124.5±9.6%; Fig. 3). Recovery of the
dephosphorylated p-radixin after GSH replenishment was signiﬁcantly
inhibited in the presence of a PKA inhibitor (42.1±5.4%; Fig. 3). Our
results suggest that the C-terminally phosphorylation status of radixin is
an important factor in the reversible interaction ofMrp2with p-radixin,
and that the balance in PKC/PKA activation is triggered by the
intracellular redox status.
3.5. Effect of protein phosphatase inhibitors on the t-BHP-induced
change in expression of radixin (A) and p-radixin (B) in IRHCs
Multiple kinases [20] and putative protein phosphatase(s) [21] are
involved in the phosphorylation and dephosphorylation of the C-
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Fig. 4. Effect of protein phosphatase inhibitors on changes in expression of radixin (B),
p-radixin (C) and Mrp2 localization (D) in IRHCs treated with t-BHP and/or GSH-EE.
IRHCs were pretreated with/without protein phosphatase inhibitors for 30 min, and
cells were subsequently treated with 100 μM t-BHP for 30 min. Total radixin expression
(B), p-radixin expression (C) and were analyzed following treatments. Cells were ﬁxed
and stained for Mrp2 analysis following treatments. The Mrp2-index was assessed as
the ratio of Mrp2-positive canaliculi per cell nucleus. Decreased p-radixin expression
and Mrp2-index, which were induced by t-BHP treatment, were suppressed by
pretreatment with 1 μM OA (PP-1 and -2A inhibitor), but not by 1 μM ET (PP-2A
selective inhibitor). Treatment with OA induced an increase in p-radixin and Mrp2
localization. Results are given as the mean±S.D. of four independent IRHCs isolations.
*pb0.05, **pb0.01, signiﬁcantly different from control.
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Moesin: Thr558), which regulate the balance between active and
inactive forms. However, the protein kinase(s) or phosphatase(s) that
are directly involved in themodiﬁcation of radixin by dephosphorylating
its C-terminus threonine (Thr564) have not been elucidated. We
investigated theeffect of serine/threoninephosphatase isoform inhibitors
on the dephosphorylation of C-terminally phosphorylated radixin in
acute oxidative stress conditions induced by t-BHP (Fig. 4A). Our results
show that total radixin expressionwas comparablewith that observed in
all treatments (Fig. 4B). The pretreatment with the protein phosphatase
(PP)-1 and -2A inhibitor, 1 μMokadaic acid (OA), for 30 min signiﬁcantly
increased p-radixin compared to the control value (129.4±8.5%) and
suppressed the t-BHP-induced decrease in p-radixin to the same extent
(123.3±10.3%; Fig. 4C). In contrast, the PP-2A selective inhibitorendothall (ET; 1 μM for 30 min) affected neither the t-BHP-induced
decrease in p-radixin content (63.2±8.5%) nor the basal expression of
p-radixin (104.2±10.7%; Fig. 4C). Inhibitor concentrations were set so
as to selectively inhibit target molecules according to the product
instructions, or previous reports [22,23]. Our data suggest that the t-
BHP-induced decrease of Thr564-phosphorylated radixin was regulated
by the activation of PP-1. PP-1 activation was also involved in the
constitutive dephosphorylation of p-radixin under normal conditions.
3.6. Effect of protein phosphatase inhibitors on the t-BHP-induced
internalization of Mrp2 in IRHCs
We investigated whether the inhibition of protein phosphatase-1
and/or -2A could inhibit t-BHP-inducedMrp2 internalization in IRHCs.
Our results conﬁrmed the effect on p-radixin. Pretreatment with the
PP-1 and -2A inhibitor OA (1 μM for 30 min) signiﬁcantly increased
the Mrp2-index compared to the control value (14.5±1.4%), and
suppressed the t-BHP-induced decrease of p-radixin content to the
same extent. In contrast, the PP-2A selective inhibitor ET (1 μM for
30 min) did not affect the t-BHP-induced decrease in the Mrp2-index
(3.8±0.8%; Fig. 4D). Our data suggest that t-BHP-induced PP-1
activation is involved in Mrp2 internalization, accompanied by the
Thr564 dephosphorylation of radixin.
4. Discussion
In the liver, Mrp2 is thought to be stably expressed in the apical
membrane by binding to radixin through the postsynaptic density-
95/discs large/zona occludens-1 (PDZ) proteins, i.e., Na+/H+ ex-
changer regulatory factor 1 (NHERF1) and PDZ domain-containing
protein 1 [8,22–24]. Dephosphorylated radixin adopts an inactive
conformation via intramolecular/intermolecular interactions between
its N-terminal and C-terminal domains. The inactive form of radixin
loses its ability to bind membrane proteins and the cytoskeleton
because its N and C termini are masked. It was reported that C-
terminally dephosphorylated mutant ezrin (T567A) is distributed
diffusely in the cytoplasm, whereas phosphorylated mutant ezrin
(T567D) is distinctly localized to themembrane surface. This indicates
that the membrane localization of radixin is strictly dependent on its
C-terminal phosphorylation status [25]. In several studies using the
rat cholestatic model, phosphorylated radixin localization was not
observed beneath the canalicular lumen [11,26]. Our data also suggest
that the p-radixin is not retained near the canalicular surface space, as
shown in Fig. 1B. Co-localization of Mrp2 and p-radixin in the
canalicular space was restored by replenishment of the GSH content
without changing total radixin expression (Figs. 1 and 2). This
suggests that dephosphorylated radixin was internalized into the
cytosolic compartment and relocated to the canalicular surface in
tandem with Thr564 phosphorylation.
Multiple kinases, which include Rho small GTPase, [27–29] and
putative protein phosphatases [21] are involved in the phosphoryla-
tion and dephosphorylation of the C-terminal threonine residue of
ERM proteins. In this study, we have shown that t-BHP induces the
dephosphorylation of p-radixin which subsequently results in the
dissociation of Mrp2 from radixin, ultimately leading to Mrp2
internalization. In contrast, p-radixin was phosphorylated after
GSH-EE treatment in a PKA-dependent manner and the association
between Mrp2 and p-radixin was restored. These are schematically
represented in Fig. 5. In previous reports, it was demonstrated that a
cell-permeable cAMP analog, dibutyryl cAMP, stimulates bile ﬂow in
the perfused rat liver [30] and sorting of Mrp2 from cytosol to the
apical membrane in IRHCs [31]. Our previous reports also stressed the
importance of the cAMP-PKA signaling pathway, where recovery of
the Mrp2-index after GSH replenishment was signiﬁcantly inhibited
in the presence of a PKA inhibitor [5]. ERM proteins and PDZ proteins
associate with PKA [32], which suggests a possible involvement of
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Bile canalicular lumen
Intracellular Pool
Mrp2
Internalization 
radixin
Mrp2
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Mrp2
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GSH-EE
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Fig. 5. Proposed role of radixin on the intracellular redox status sensitive Mrp2 localization. t-BHP-induced GSH decrease causes dephosphorylation of p-radixin and subsequently
results in the dissociation of Mrp2 from radixin, ultimately leading to Mrp2 internalization. In contrast, p-radixin is phosphorylated after replenishment of GSH in a PKA-dependent
manner and the association between Mrp2 and p-radixin was restored, which returned Mrp2 localization to its normal status. *1: We have reported that t-BHP-induced GSH
decrease causes Ca2+ elevation and NO release and ﬁnally leads to PKC activation in IRHCs [3]. *2: dibutyryl cAMP, stimulates sorting of Mrp2 from cytosol to the apical membrane in
IRHCs [31]. Our previous reports also show that decreased cAMP content induced by t-BHP was signiﬁcantly increased during the replenishment of GSH content in IRHCs and
recovery of the Mrp2-index after GSH replenishment was signiﬁcantly inhibited in the presence of a PKA inhibitor [5].
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canalicular surface. We found that the reduction in p-radixin and its
interaction with Mrp2 were completely restored with the replenish-
ment of intrahepatic GSH. These effects were signiﬁcantly inhibited by
pretreatment with a PKA inhibitor (Figs. 2 and 3). From these
observations, it can be concluded that the activity balance of PKC and
PKA, which depends on GSH content, regulates the phosphorylation
status of p-radixin. This subsequently modulates the interaction of p-
radixin with Mrp2, and ﬁnally leads to Mrp2 localization in a
reversible manner.
We have shown that decreases in p-radixin and the Mrp2-index,
which were induced by t-BHP treatment, could be prevented by non-
speciﬁc inhibitors of PP-1 and PP-2A (OA 1 μM; IC50; PP-1: 10–15 nM,
PP-2A: 0.1 nM), but not by a PP-2A selective inhibitor (ET 1 μM; IC50;
PP-1: 5 μM, PP-2A: 90 nM). Our preliminary studies conﬁrmed the
molecular interactions of the catalytic subunit isotype (phosphopro-
tein phosphatase-1 catalytic subunit α: PPP-1Cα) with C-terminal
cytosolic region of Mrp2, indicating the substrate speciﬁcity of PP-1
for both Mrp2 and radixin. Our data suggest that PP-1 is involved in t-
BHP-induced Mrp2 internalization resulting from the dephosphory-
lation of Thr564 in radixin. Using our experimental conditions, it is
unclear whether PP-1 is actually activated following PKC though a
previous report showed that PP-1 (but not PP-2A) activity was
selectively down-regulated in PKCα-deﬁcient mice [33]. PP-1 activity
is suppressed in cardiac myocytes by protein phosphatase inhibitor-1
(PPI-1), but PKCα-dependent phosphorylation of PPI-1 at Ser67 leads
to the dissociation of PPI-1 from PP-1, resulting in PP-1 activation.PKA-dependent phosphorylation of PPI-1 at Thr35 results in the
association of PPI-1 with PP-1, which ﬁnally leads to its inactivation
[34]. These observations suggest that PP-1 activity is modulated by the
phosphorylation of PPI-1, which is in turn mediated by the balance of
PKC and PKA activation. Although, we did not determine whether the
phosphorylation status of PPI-1 was altered by the intracellular redox
status in IRHCs, this is a possible mechanism for PKC-mediated PP-1
activation.
Oxidative stress markers, including the increase of major lipid
peroxidation (malondialdehyde and 4-hydroxynonenal) metabolites
and those indicating a decline in the anti-oxidant status (total GSH
and vitamin A and C), closely correlate with the progression of chronic
cholestatic disorder in patients with chronic hepatic failure (PBC and
hepatitis C virus infection) [2,35]. In these patients, the disruption of
the canalicular localization of MRP2, in the absence of changes in
expression levels, is probably caused by a shortage of radixin around
the canalicular region, as demonstrated in the liver of PBC patients [1].
We also found that LPS induced the dephosphorylation of radixin and
the disruption of the binding between Mrp2 and radixin, which
decreased the expression of Mrp2 on the apical membrane, thereby
leading to the internalization of Mrp2 in rat liver [11]. We have
demonstrated that LPS-induced oxidative stress is a trigger factor that
commonly regulatesMrp2/MRP2 internalization in both rat and human
livers [36]. Observations strongly suggest that the phosphorylation
status of Thr564 radixin might be a key factor in cholestatic jaundice,
which is accompanied by MRP2/Mrp2 internalization in both human
and rat livers.
1434 S. Sekine et al. / Biochimica et Biophysica Acta 1812 (2011) 1427–1434In conclusion, we found that the balance of activation of PKA and
PKC, mediated by variations in intercellular GSH, determines the
phosphorylation status of radixin, which subsequently results in
redox-sensitive canalicular Mrp2 localization.
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